Fayez Sarofim & CO Zoetis Inc. Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Zoetis Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 1,030,918 shares of ZTS stock, worth $168 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

1,030,918

Previous 953,518 8.12%

Holding current value

$168 Million

Previous $165 Million 21.85%

% of portfolio

0.52%

Previous 0.45%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $13.4 Million - $15.2 Million	77,400 Added 8.12%	1,030,918 $201 Million
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $16.5 Million - $20.3 Million	113,708 Added 13.54%	953,518 $165 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $25.3 Million - $30.5 Million	152,459 Added 22.18%	839,810 $142 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $1.59 Million - $2.11 Million	10,531 Added 1.56%	687,351 $136 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $13.3 Million - $15.3 Million	79,620 Added 13.33%	676,820 $118 Million
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $221,775 - $256,624	-1,378 Reduced 0.23%	597,200 $103 Million
Q1 2023 May 11, 2023	BUY	$145.48 - $175.02 $3.96 Million - $4.76 Million	27,210 Added 4.76%	598,578 $99.6 Million
Q4 2022 Feb 13, 2023	BUY	$131.14 - $157.47 $8.06 Million - $9.67 Million	61,431 Added 12.05%	571,368 $83.8 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1.39 Million - $1.71 Million	9,342 Added 1.87%	509,937 $75.6 Million
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $2.24 Million - $2.87 Million	14,353 Added 2.95%	500,595 $86 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $1.95 Million - $2.51 Million	-10,744 Reduced 2.16%	486,242 $91.7 Million
Q4 2021 Feb 11, 2022	SELL	$193.69 - $247.03 $278,138 - $354,735	-1,436 Reduced 0.29%	496,986 $121 Million
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $2.67 Million - $2.95 Million	14,081 Added 2.91%	498,422 $96.8 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $1.73 Million - $2.08 Million	11,088 Added 2.34%	484,341 $90.3 Million
Q1 2021 May 13, 2021	BUY	$144.0 - $169.39 $37.4 Million - $44 Million	259,974 Added 121.89%	473,253 $74.5 Million
Q4 2020 Feb 11, 2021	BUY	$157.07 - $174.35 $19,633 - $21,793	125 Added 0.06%	213,279 $35.3 Million
Q3 2020 Nov 13, 2020	SELL	$137.1 - $165.37 $304,224 - $366,956	-2,219 Reduced 1.03%	213,154 $35.3 Million
Q2 2020 Aug 11, 2020	SELL	$111.92 - $142.53 $2.07 Million - $2.64 Million	-18,500 Reduced 7.91%	215,373 $29.5 Million
Q1 2020 May 12, 2020	SELL	$92.66 - $144.94 $116,566 - $182,334	-1,258 Reduced 0.54%	233,873 $27.5 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $95,325 - $109,265	820 Added 0.35%	235,131 $31.1 Million
Q3 2019 Nov 13, 2019	BUY	$112.57 - $128.43 $70,806 - $80,782	629 Added 0.27%	234,311 $29.2 Million
Q2 2019 Aug 09, 2019	SELL	$97.98 - $114.28 $194,980 - $227,417	-1,990 Reduced 0.84%	233,682 $26.5 Million
Q4 2018 Feb 13, 2019	BUY	$79.28 - $95.27 $55,020 - $66,117	694 Added 0.3%	235,672 $20.2 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $148,212 - $165,483	-1,775 Reduced 0.75%	234,978 $21.5 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $5,513 - $6,154	-69 Reduced 0.03%	236,753 $20.2 Million
Q1 2018 May 10, 2018	SELL	$71.51 - $84.69 $287,112 - $340,030	-4,015 Reduced 1.67%	236,822 $19.8 Million
Q4 2017 Feb 13, 2018	SELL	$63.24 - $72.8 $41,422 - $47,684	-655 Reduced 0.27%	240,837 $17.4 Million
Q3 2017 Nov 08, 2017	BUY	$59.73 - $65.4 $14.4 Million - $15.8 Million	241,492	241,492 $15.4 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account